SacubitrilValsartan | 中藥處方小百科
由DNicolas著作·2021·被引用6次—Sacubitril/valsartanisthefirstagenttobeapprovedinanewclassofdrugscalledangiotensinreceptorneprilysininhibitor(ARNI).
Continuing Education ActivitySacubitril/valsartan is the first agent to be approved in a new class of drugs called angiotensin receptor neprilysin inhibitor (ARNI). The medication is FDA-approved to treat patients with chronic heart failure with reduced ejection fraction (HFrEF) with NYHA class II, III, or IV. Sacubitril/valsartan is to be used in place of an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker and conjunction with other standard heart-failure treatments (beta-blocker, aldosterone antagonist). Patients must be able to tolerate ACEI or ARB before starting on sacubitril/valsartan. This activity outlines the indications, mechanism of action, methods of administration, important adverse effects, contraindications, toxicity, and monitoring of sacubitril/valsartan, so providers can direct patient therapy in conditions where it is ...
10602 8 | 中藥處方小百科
Effect of Treatment With SacubitrilValsartan in Patients With ... | 中藥處方小百科
Entresto (sacubitrilvalsartan) dosing | 中藥處方小百科
Sacubitril Valsartan 健安心藥物使用須知 | 中藥處方小百科
SacubitrilValsartan | 中藥處方小百科
SacubitrilValsartan 口服製劑衛教單張 | 中藥處方小百科
Sacubitrilvalsartan | 中藥處方小百科
【篤實關懷倫理卓越】光田綜合醫院Kuang Tien General Hospital | 中藥處方小百科
【“晉安”百合濃縮細粒
Bar Her Ext. Sybtly Granule "C.A."】衛署藥製字第042300號
產品名稱:“晉安”百合濃縮細粒 BarHerExt.SybtlyGranule"C.A."濃縮顆粒劑:濃縮顆粒劑調劑專用適應症及效能:適應症:效能:潤...